Solesence to Start Trading on Nasdaq as SLSN from April 8

Solesence, Inc. (OTCQB: NANX) announced that it has been approved for listing on the Nasdaq Capital Market, with trading scheduled to begin under the new ticker SLSN on Tuesday, April 8, 2025. The move from the OTCQB exchange marks a significant step for the company, although shareholders are not required to take any specific action as a result of the uplisting. The decision comes after the company met all necessary requirements outlined by Nasdaq’s Listing Qualifications Department.

CEO highlights company vision and Nasdaq’s potential impact

Following the approval, Solesence CEO Jess Jankowski noted that the transition represents an important milestone for the company’s presence in the public markets. Referring to the company's core innovations in mineral-based skincare, Jankowski emphasized how beauty brands are increasingly aligning with their product offerings, stating, “Solesence continues to redefine mineral-based sun protection as beauty brands recognize the novel skin health benefits from our award-winning products.” He also pointed to the strategic benefits of the move, which he believes will help broaden investor interest and increase the firm’s visibility in the financial sector.

Operational outlook and team contribution

Kevin Cureton, Chief Operating Officer at Solesence, shared further insights into what the Nasdaq listing could enable in the long term. He remarked that the uplisting is the result of ongoing efforts to maintain profitability while expanding the company’s reach in the industry. “We’re particularly excited about how Solesence’s uplisting to Nasdaq may one day provide resources to enable our company to scale and increase profitability in a manner not available to most of our competitors,” said Cureton, attributing the achievement to internal efforts, brand partnerships, and shareholder patience.

Company background and strategic direction

Solesence, Inc. operates at the intersection of beauty and life sciences, offering solutions that combine protection, prevention, and treatment in daily-use products. Known for its science-driven approach, the company has developed mineral-based sun care technologies that focus on transparency, wearability, and effectiveness. By collaborating with brands, Solesence enables differentiated product claims through the integration of skincare and sun protection technologies.

Cautionary note on forward-looking statements

The company also issued a standard disclaimer regarding forward-looking statements, noting that any expectations described are subject to various risks and uncertainties. Factors such as shifting customer demands, market conditions, and regulatory developments could all influence future outcomes. Details of these risks are available in Solesence’s latest Form 10-K, filed on March 31, 2025.